Table 2. Forearm blood flow (ml/min per 100 ml) in patients with chronic kidney disease (CKD) and in controls in the baseline and during insulin infusion.
Insulin infusion rate (mU/kg per min) | |||||||||
---|---|---|---|---|---|---|---|---|---|
0.01 |
0.035 |
||||||||
0 | 80 | 100 | 120 | 0 | 80 | 100 | 120 min | ||
Controls (n= 5) | 3.5±0.2 | 3.7±0.1 | 3.6±0.2 | 3.7±0.2 | Controls (n=7) | 3.7±0.1 | 4.2±0.3 | 4.6±0.1a | 4.7±0.2a |
CKD (n= 5) | 4.1±0.2 | 4.0±0.2 | 3.8±0.26 | 4.0±0.3 | CKD (n=7) | 4.2±0.4 | 4.9±0.6 | 4.9±0.4a | 5.1±0.4a |
P⩽0.05 basal versus insulin-infused period.